Genmab — Maj 2021
-
Jeg ser på det i morgen. Skal se dyner.. Godnat herfra.
-
Øh...'Såfremt' der er en 'eventuel' milestone, så fortæller vi det først om tre måneder. Ikke at en milestone nødvendigvis er voldsomt afgørende, og når de ikke meddeler det, er der jo nok ikkenogen, men det er der så måske eventuelt alligevel, hvis det viser sig...
-
This review was conducted under Project Orbis, an initiative of the FDA Oncology Center of Excellence. Project Orbis provides a framework for concurrent submission and review of oncology drugs among international partners. For this review, the FDA collaborated with the Brazilian Health Regulatory Agency and United Kingdom’s Medicines and Healthcare products Regulatory Agency.
-
I øvrigt nævner Janssen ikke Genmab eller Duobody med så meget som et halvt ord https://www.janssen.com/us/sites/www_janssen_com_usa/files/rybrevanttm_amivantamab-vmjw_receives_fda_approval_as_the_first_targeted_treatment_for_patients_with_non-small_cell_lung_cancer_with_egfr_exon_20_insertion_mutations.pdf
-
God morgen.
-
En subkutan version af amivantamab på vej https://meetinglibrary.asco.org/record/201164/abstract
-
Sukker, ja det store Mariposa studie med 1000 pts har primary completion april 24. https://clinicaltrials.gov/ct2/show/NCT04487080?term=Amivantamab&draw=2&rank=4
-
Gentogen, i ansøgningen fra 3. dec nævner de dog genmab. https://www.jnj.com/janssen-submits-application-to-u-s-fda-seeking-approval-of-amivantamab-for-the-treatment-of-patients-with-metastatic-non-small-cell-lung-cancer-with-egfr-exon-20-insertion-mutations
-
Phase I study investigating the safety of stereotactic body radiotherapy (SBRT) with anti-PD-1 and anti-IL-8 for the treatment of multiple metastases in advanced solid tumors. https://meetinglibrary.asco.org/record/201166/abstract
-
Early stage. Jeg har i dag oprettet en
Proinvestor Youtube kanal. Her vil der fremover komme masser af interviews og præsentationer med biotekfirmaer. Til produktionen har jeg hyret et stærkt team ind som tidligere har arbejdet i bla. DR som studievært, videoproduktion og redigering. Sign up her: https://www.youtube.com/watch?v=teTBHPJusm0 -
PS: Giv vores første reklamevideo et like. På forhånd tak og forsat god pinse.
-
Fra E L lagt i Aktiesnakken ved en fejl kl. 9,50: "JNJ's version of Amivantamab development" https://twitter.com/JNJNews/status/1395828935330607104
-
Se mit svar i tråden fra JNJ.
-
Tak Stroka. Jan beholder vi i vores vante Q&A format.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind